Metronomic chemotherapy for triple negative breast cancer?

by Di Desidero, Teresa, Kerbel, Robert S., Bocci, Guido
Published in Aging (Albany NY) (2016)

Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer Cells

by Di Desidero, Teresa, Orlandi, Paola, Gentile, Daniela, Bocci, Guido
Published in Front Oncol (2019)

Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer

by Di Desidero, Teresa, Xu, Ping, Man, Shan, Bocci, Guido, Kerbel, Robert S.
Published in Oncotarget (2015)

Simultaneous, But Not Consecutive, Combination With Folinate Salts Potentiates 5-Fluorouracil Antitumor Activity In Vitro and In Vivo

by Di Paolo, Antonello, Orlandi, Paola, Di Desidero, Teresa, Danesi, Romano, Bocci, Guido
Published in Oncol Res (2017)

Optimization of biomarkers-based classification scores as progression-free survival predictors: an intuitive graphical representation

by Manciu, Marian, Hosseini, Sorour, Di Desidero, Teresa, Allegrini, Giacomo, Falcone, Alfredo, Bocci, Guido, Kirken, Robert A, Francia, Giulio
Published in Future Sci OA (2018)

Metronomic Ceramide Analogs Inhibit Angiogenesis in Pancreatic Cancer through Up-regulation of Caveolin-1 and Thrombospondin-1 and Down-regulation of Cyclin D1

by Bocci, Guido, Fioravanti, Anna, Orlandi, Paola, Di Desidero, Teresa, Natale, Gianfranco, Fanelli, Giovanni, Viacava, Paolo, Naccarato, Antonio Giuseppe, Francia, Giulio, Danesi, Romano
Published 2012

Synergistic efficacy of irinotecan and sunitinib combination in preclinical models of anaplastic thyroid cancer

by Di Desidero, Teresa, Antonelli, Alessandro, Orlandi, Paola, Ferrari, Silvia Martina, Fioravanti, Anna, Alì, Greta, Fontanini, Gabriella, Basolo, Fulvio, Francia, Giulio, Bocci, Guido
Published in Cancer Lett (2017)

Irinotecan Synergistically Enhances the Antiproliferative and Proapoptotic Effects of Axitinib In Vitro and Improves Its Anticancer Activity In Vivo

by Canu, Bastianina, Fioravanti, Anna, Orlandi, Paola, Di Desidero, Teresa, Alì, Greta, Fontanini, Gabriella, Di Paolo, Antonello, Del Tacca, Mario, Danesi, Romano, Bocci, Guido
Published 2011

Dual Kit/Aur Inhibitors as Chemosensitizing Agents for the Treatment of Melanoma: Design, Synthesis, Docking Studies and Functional Investigation

by Quattrini, Luca, Coviello, Vito, Sartini, Stefania, Di Desidero, Teresa, Orlandi, Paola, Ke, Yi-Yu, Liu, Kai-Lun, Hsieh, Hsing-Pang, Bocci, Guido, La Motta, Concettina
Published in Sci Rep (2019)

The rs2071559 AA VEGFR-2 Genotype Frequency Is Significantly Lower in Neovascular Age-Related Macular Degeneration Patients

by Lazzeri, Stefano, Orlandi, Paola, Figus, Michele, Fioravanti, Anna, Cascio, Elisa, Di Desidero, Teresa, Agosta, Elisa, Canu, Bastianina, Sartini, Maria Sole, Danesi, Romano, Nardi, Marco, Bocci, Guido
Published 2012

Pharmacological effects of vinorelbine in combination with lenvatinib in anaplastic thyroid cancer

by Di Desidero, Teresa, Orlandi, Paola, Gentile, Daniela, Banchi, Marta, Alì, Greta, Kusmic, Claudia, Armanetti, Paolo, Cayme, Ginelle J., Menichetti, Luca, Fontanini, Gabriella, Francia, Giulio, Bocci, Guido
Published in Pharmacol Res (2020)

Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth

by Parra, Karla, Valenzuela, Paloma, Lerma, Natzidielly, Gallegos, Alejandra, Reza, Luis C, Rodriguez, Georgialina, Emmenegger, Urban, Di Desidero, Teresa, Bocci, Guido, Felder, Mitchell S, Manciu, Marian, Kirken, Robert A, Francia, Giulio
Published in Br J Cancer (2017)

Genetic interaction of P2X(7) receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients

by Solini, Anna, Simeon, Vittorio, Derosa, Lisa, Orlandi, Paola, Rossi, Chiara, Fontana, Andrea, Galli, Luca, Di Desidero, Teresa, Fioravanti, Anna, Lucchesi, Sara, Coltelli, Luigi, Ginocchi, Laura, Allegrini, Giacomo, Danesi, Romano, Falcone, Alfredo, Bocci, Guido
Published in Oncotarget (2015)

Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers

by Allegrini, Giacomo, Di Desidero, Teresa, Barletta, Maria Teresa, Fioravanti, Anna, Orlandi, Paola, Canu, Bastianina, Chericoni, Silvio, Loupakis, Fotios, Di Paolo, Antonello, Masi, Gianluca, Fontana, Andrea, Lucchesi, Sara, Arrighi, Giada, Giusiani, Mario, Ciarlo, Andrea, Brandi, Giovanni, Danesi, Romano, Kerbel, Robert S., Falcone, Alfredo, Bocci, Guido
Published 2012